LYSOVETA® by Aker BioMarine
LYSOVETA® by Aker BioMarine
LYSOVETA® by Aker BioMarine is a krill-derived marine phospholipid ingredient featuring lysophosphatidylcholine-bound EPA and DHA, produced through a patent-protected, scalable process. Its distinctive molecular structure aligns with MFSD2A-mediated fatty acid transport across the blood-brain and blood-retinal barriers, creating opportunities for targeted omega-3 delivery research. Sustainably sourced from Antarctic krill, LYSOVETA® offers manufacturers and research partners a differentiated platform for brain health, eye health, and lifespan development formulations, supported by ongoing scientific exploration of LPC-mediated nutrient transport.
0 out of 5 stars (based on 0 endorsements)
General
Item #:
Company:
Technology:
Name:
LYSOVETA®
Ingredient/s:
Categories:
Brain Health, Cellular Health, Cognitive Health, Eye Health, General Health
Dosage (min):
Dosage (max):
MOQ:
Price kg:
Botanicals:
Euphausia superba (Antarctic Krill)
Active/s:
Lysophosphatidylcholine-Bound Eicosapentaenoic Acid (LPC-EPA), Lysophosphatidylcholine-Bound Docosahexaenoic Acid (LPC-DHA)
Assay:
Country of Origin:
Suppliers:
Aker BioMarine
Contact Information
Email: info@nxtingredients.com
Documents (Coming Soon)
Upgrade your account to access documents
COMING SOON
Ingredient Highlights
- Supports targeted omega-3 delivery to brain tissues.*
- Promotes brain health through LPC-bound EPA and DHA.*
- Supports eye health through retinal omega-3 transport.*
- Promotes cognitive health through targeted fatty acid delivery.*
- Supports cellular health through phospholipid-bound omega-3s.*
- Supports general wellness through marine lipid nutrition.*
Ingredient Overview
Cheat Sheet Card
100% Natural
Vegan
Gluten Free
Non-GMO
GRAS
Water Soluble
Wild-Harvested
Allergen Free
Key Certifications
Halal Certified
Kosher Certified
Vegan Certified
USDA Organic
NON-GMO Project Verified
Gluten-Free Certified
Send an Inquiry
Ingredient Highlights
Research Library - Coming Soon
Featured Content
Product type
Related Articles
Global Regulatory Market Access Status - Coming Soon
Endorsement
0 out of 5 stars (based on 0 endorsements)
There are no reviews yet. Be the first one to write one.
